Page last updated: 2024-08-24

adenosine and Shock, Cardiogenic

adenosine has been researched along with Shock, Cardiogenic in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's6 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanic, V; Kanic, Z; Kompara, G; Markota, A; Penko, M; Vollrath, M1
Backhaus, T; Fach, A; Fiehn, E; Garstka, D; Hambrecht, R; Schmucker, J; Stehmeier, J; Wienbergen, H1
Bonello, L; Cautella, J; Colomb, B; Cordier, C; Fenouillet, E; Gaubert, M; Guieu, R; Kerbaul, F; Kipson, N; Laine, M; Marlinge, M; Mottola, G; Paganelli, F; Resseguier, N; Ruf, J; Thuny, F1
Delle Karth, G; Siller-Matula, JM1
Aslan, Y; Celiker, A; Dilber, B; Dilber, E; Gedik, Y; Mutlu, M1
Hausleiter, J; Joner, M; Kastrati, A; Massberg, S; Okrojek, R; Orban, M; Riegger, J; Sibbing, D; Tada, T1
Hussain, F1
Kloner, RA1

Reviews

2 review(s) available for adenosine and Shock, Cardiogenic

ArticleYear
[Dual platelet inhibitors in intensive care units].
    Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2014, Volume: 109, Issue:6

    Topics: Acute Coronary Syndrome; Adenosine; Aged; Clopidogrel; Germany; Guideline Adherence; Hemorrhage; Humans; Hypothermia, Induced; Intensive Care Units; Myocardial Infarction; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Precision Medicine; Risk Assessment; Shock, Cardiogenic; Survival Rate; Ticagrelor; Ticlopidine; Treatment Outcome

2014
Preinfarct angina and exercise: yet another reason to stay physically active.
    Journal of the American College of Cardiology, 2001, Nov-01, Volume: 38, Issue:5

    Topics: Adenosine; Age Factors; Aged; Angina Pectoris; Arrhythmias, Cardiac; Collateral Circulation; Coronary Circulation; Exercise; Hospital Mortality; Humans; Ischemic Preconditioning, Myocardial; Middle Aged; Myocardial Infarction; Prognosis; Shock, Cardiogenic; Treatment Outcome

2001

Other Studies

6 other study(ies) available for adenosine and Shock, Cardiogenic

ArticleYear
GPIIb-IIIa Receptor Inhibitors in Acute Coronary Syndrome Patients Presenting With Cardiogenic Shock and/or After Cardiopulmonary Resuscitation.
    Heart, lung & circulation, 2018, Volume: 27, Issue:1

    Topics: Acute Coronary Syndrome; Adenosine; Aged; Cardiopulmonary Resuscitation; Cause of Death; Clopidogrel; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Retrospective Studies; Risk Factors; Shock, Cardiogenic; Slovenia; Survival Rate; Ticagrelor; Ticlopidine; Time Factors

2018
Management and predictors of outcome in unselected patients with cardiogenic shock complicating acute ST-segment elevation myocardial infarction: results from the Bremen STEMI Registry.
    Clinical research in cardiology : official journal of the German Cardiac Society, 2018, Volume: 107, Issue:5

    Topics: Adenosine; Aged; Chi-Square Distribution; Comorbidity; Drug-Eluting Stents; Female; Germany; Heart-Assist Devices; Hospital Mortality; Humans; Intra-Aortic Balloon Pumping; Logistic Models; Male; Middle Aged; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Prasugrel Hydrochloride; Registries; Risk Factors; Shock, Cardiogenic; ST Elevation Myocardial Infarction; Ticagrelor; Time Factors; Treatment Outcome

2018
Adenosine Plasma Level and A2A Receptor Expression in Patients With Cardiogenic Shock.
    Critical care medicine, 2018, Volume: 46, Issue:9

    Topics: Adenosine; Aged; Blood Pressure; Female; Heart Failure; Humans; Male; Myocardial Contraction; Myocardial Infarction; Prospective Studies; Receptor, Adenosine A2A; Shock, Cardiogenic; Vasodilation

2018
Intravenous amiodarone used alone or in combination with digoxin for life-threatening supraventricular tachyarrhythmia in neonates and small infants.
    Pediatric emergency care, 2010, Volume: 26, Issue:2

    Topics: Adenosine; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Digoxin; Drug Evaluation; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Defects, Congenital; Heart Failure; Heart Neoplasms; Heart Rate; Humans; Hypotension; Infant; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Male; Retrospective Studies; Rhabdomyoma; Shock, Cardiogenic; Tachycardia, Supraventricular; Thyrotropin; Treatment Outcome

2010
Dual thienopyridine low-response to clopidogrel and prasugrel in a patient with STEMI, cardiogenic shock and early stent thrombosis is overcome by ticagrelor.
    Platelets, 2012, Volume: 23, Issue:5

    Topics: Adenosine; Aged; Cardiopulmonary Resuscitation; Clopidogrel; Humans; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Shock, Cardiogenic; Stents; Thiophenes; Thrombosis; Ticagrelor; Ticlopidine

2012
Adenosine conditioning and pacing in conjunction with early intra-aortic balloon pump use and glycoprotein IIb/IIIa inhibition to accomplish complete multivessel revascularization in an octogenarian with profound cardiogenic shock.
    The Journal of invasive cardiology, 2007, Volume: 19, Issue:10

    Topics: Adenosine; Aged, 80 and over; Angioplasty, Balloon, Coronary; Combined Modality Therapy; Coronary Angiography; Coronary Vessels; Female; Humans; Intra-Aortic Balloon Pumping; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Pacemaker, Artificial; Platelet Glycoprotein GPIIb-IIIa Complex; Severity of Illness Index; Shock, Cardiogenic; Stents

2007